Vis enkel innførsel

dc.contributor.authorBosch de Basea Gomez, Magda
dc.contributor.authorThierry-Chef, Isabelle
dc.contributor.authorHarbron, Richard
dc.contributor.authorHauptmann, Michael
dc.contributor.authorByrnes, Graham
dc.contributor.authorBernier, Maria-Odile
dc.contributor.authorLe Cornet, Lucian
dc.contributor.authorDabin, Jérémie
dc.contributor.authorFerro, Gilles
dc.contributor.authorIstad, Tore S.
dc.contributor.authorJahnen, Andreas
dc.contributor.authorLee, Choonsik
dc.contributor.authorMaccia, Carlo
dc.contributor.authorMalchair, Françoise
dc.contributor.authorOlerud, Hilde Merete
dc.contributor.authorSimon, Steven L.
dc.contributor.authorFiguerola, Jordi
dc.contributor.authorPeiro, Anna
dc.contributor.authorEngels, Hilde
dc.contributor.authorJohansen, Christoffer
dc.contributor.authorBlettner, Maria
dc.contributor.authorKaijser, Magnus
dc.contributor.authorKjærheim, Kristina
dc.contributor.authorBerrington de Gonzalez, Amy
dc.contributor.authorJourny, Neige
dc.contributor.authorMeulepas, Johanna M.
dc.contributor.authorMoissonnier, Monika
dc.contributor.authorNordenskjold, Arvid
dc.contributor.authorPokora, Roman
dc.contributor.authorRonckers, Cecile
dc.contributor.authorSchüz, Joachim
dc.contributor.authorKesminiene, Ausrele
dc.contributor.authorCardis, Elisabeth
dc.date.accessioned2024-06-05T10:18:12Z
dc.date.available2024-06-05T10:18:12Z
dc.date.created2023-11-28T13:29:22Z
dc.date.issued2023
dc.identifier.citationBosch de Basea Gomez, M., Thierry-Chef, I., Harbron, R., Hauptmann, M., Byrnes, G., Bernier, M.-O., Le Cornet, L., Dabin, J., Ferro, G., Istad, T. S., Jahnen, A., Lee, C., Maccia, C., Malchair, F., Olerud, H., Simon, S. L., Figuerola, J., Peiro, A., Engels, H., . . . Cardis, E. (2023). Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nature Medicine, 29(12), 3111-3119.en_US
dc.identifier.issn1078-8956
dc.identifier.urihttps://hdl.handle.net/11250/3132661
dc.description.abstractOver one million European children undergo computed tomography (CT) scans annually. Although moderate- to high-dose ionizing radiation exposure is an established risk factor for hematological malignancies, risks at CT examination dose levels remain uncertain. Here we followed up a multinational cohort (EPI-CT) of 948,174 individuals who underwent CT examinations before age 22 years in nine European countries. Radiation doses to the active bone marrow were estimated on the basis of body part scanned, patient characteristics, time period and inferred CT technical parameters. We found an association between cumulative dose and risk of all hematological malignancies, with an excess relative risk of 1.96 (95% confidence interval 1.10 to 3.12) per 100 mGy (790 cases). Similar estimates were obtained for lymphoid and myeloid malignancies. Results suggest that for every 10,000 children examined today (mean dose 8 mGy), 1–2 persons are expected to develop a hematological malignancy attributable to radiation exposure in the subsequent 12 years. Our results strengthen the body of evidence of increased cancer risk at low radiation doses and highlight the need for continued justification of pediatric CT examinations and optimization of doses.en_US
dc.language.isoengen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleRisk of hematological malignancies from CT radiation exposure in children, adolescents and young adultsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© The Author(s) 2023.en_US
dc.source.pagenumber3111-3119en_US
dc.source.volume29en_US
dc.source.journalNature Medicineen_US
dc.source.issue12en_US
dc.identifier.doihttps://doi.org/10.1038/s41591-023-02620-0
dc.identifier.cristin2203912
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal